A phase 2, randomized, placebo-controlled, double-blind, ascending dose study to evaluate efficacy, safety, tolerability, pharmacokinetics, pharmacodynamics & pharmacogenetics of CC-220 in subjects with SLE

被引：0
|
作者：
Werth, V. [1 ]
Furie, R. [2 ]
Hough, D. [3 ]
Korish, S. [3 ]
Weiswasser, M. [3 ]
Azarian, A. [3 ]
Schafer, P. [3 ]
Delev, N. [3 ]
Choi, S. [3 ]
机构：
[1] UPenn, Philadelphia, PA USA
[2] Northwell Hlth, Great Neck, NY USA
[3] Celgene, Summit, NJ USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2017年 / 137卷 / 05期
关键词：
D O I：
10.1016/j.jid.2017.02.396
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
379
引用
收藏
页码：S65 / S65
页数：1
相关论文
共 50 条
  • [31] Vivacity-MG: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Nipocalimab Administered to Adults with Generalized Myasthenia Gravis
    Guptill, Jeffrey
    Antozzi, Carlo
    Bril, Vera
    Gamez, Josep
    Meuth, Sven G.
    Blanco, Jose Luis Munoz
    Nowak, Richard J.
    Quan, Dianna
    Sevilla, Teresa
    Szczudlik, Andrzej
    Hegarty, Brooke
    Jouvin, Marie-Helene
    Jin, Jim
    Arroyo, Santiago
    NEUROLOGY, 2021, 96 (15)
  • [32] Liraglutide's Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Pediatric Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
    Klein, David J.
    Battelino, Tadej
    Chatterjee, D. J.
    Jacobsen, Lisbeth V.
    Hale, Paula M.
    Arslanian, Silva
    DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 (10) : 679 - 687
  • [33] Safety, tolerability and efficacy of intra-articular Progenza in knee osteoarthritis: a randomized double-blind placebo-controlled single ascending dose study
    Kuah, D.
    Sivell, S.
    Longworth, T.
    James, K.
    Guermazi, A.
    Cicuttini, F.
    Wang, Y.
    Craig, S.
    Comin, G.
    Robinson, D.
    Wilson, J.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 16
  • [34] Safety, tolerability and efficacy of intra-articular Progenza in knee osteoarthritis: a randomized double-blind placebo-controlled single ascending dose study
    D. Kuah
    S. Sivell
    T. Longworth
    K. James
    A. Guermazi
    F. Cicuttini
    Y. Wang
    S. Craig
    G. Comin
    D. Robinson
    J. Wilson
    Journal of Translational Medicine, 16
  • [35] A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome
    Nyhlin, H
    Bang, C
    Elsborg, L
    Silvennoinen, J
    Holme, I
    Rüegg, P
    Jones, J
    Wagner, A
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2004, 39 (02) : 119 - 126
  • [36] A phase 2, double-blind, randomized, placebo-controlled, dose-escalation study to evaluate the efficacy, safety, and tolerability of naloxegol in patients with opioid-induced constipation
    Webster, Lynn
    Dhar, Sunita
    Eldon, Michael
    Masuoka, Lorianne
    Lappalainen, Jaakko
    Sostek, Mark
    PAIN, 2013, 154 (09) : 1542 - 1550
  • [37] A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
    Targan, Stephan R.
    Feagan, Brian G.
    Vermeire, Severine
    Panaccione, Remo
    Melmed, Gil Y.
    Blosch, Consuelo
    Newmark, Richard
    Zhang, Nan
    Chon, Yun
    Lin, Shao-Lee
    Klekotka, Paul
    GASTROENTEROLOGY, 2012, 143 (03) : E26 - E26
  • [38] A Randomized, Double-Blinded, Placebo-Controlled, Ascending Dose Study Of The Safety, Tolerability, And Pharmacokinetics Of ®Xmab 7195
    Gershman, A.
    Goldwater, R.
    Foster, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [39] A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study to Evaluate the Efficacy and Safety of RIST4721 in Subjects with Palmoplantar Pustulosis
    Robert Bissonnette
    Catherine Maari
    Athanasios Tsianakas
    DeAnne Reid
    Sara McCutchan
    Scott Baumgartner
    James Mackay
    Nihar Bhakta
    Dermatology and Therapy, 2021, 11 : 2179 - 2193
  • [40] A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study to Evaluate the Efficacy and Safety of RIST4721 in Subjects with Palmoplantar Pustulosis
    Bissonnette, Robert
    Maari, Catherine
    Tsianakas, Athanasios
    Reid, DeAnne
    McCutchan, Sara
    Baumgartner, Scott
    Mackay, James
    Bhakta, Nihar
    DERMATOLOGY AND THERAPY, 2021, 11 (06) : 2179 - 2193
12345